Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice.

× No keyword cloud information.

33 in total

Review 1. Vaccines for Alzheimer's disease: how close are we?

Authors: Christopher Janus
Journal: CNS Drugs Date: 2003 Impact factor: 5.749

Review 2. Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Authors: Lisa M Kosloski; Duy M Ha; Jessica A L Hutter; David K Stone; Michael R Pichler; Ashley D Reynolds; Howard E Gendelman; R Lee Mosley
Journal: J Neurochem Date: 2010-05-26 Impact factor: 5.372

Review 3. Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors: Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal: Curr Pharm Des Date: 2012 Impact factor: 3.116

Review 4. T-cells in Alzheimer's disease.

Authors: Terrence Town; Jun Tan; Richard A Flavell; Mike Mullan
Journal: Neuromolecular Med Date: 2005 Impact factor: 3.843

5. Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Authors: Katharina Schindowski; Anne Eckert; Jürgen Peters; Corinna Gorriz; Uta Schramm; Thomas Weinandi; Konrad Maurer; Lutz Frölich; Walter E Müller
Journal: Neuromolecular Med Date: 2007-10-26 Impact factor: 3.843

Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice.

Review 1. Vaccines for Alzheimer's disease: how close are we?

Review 2. Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Review 3. Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Review 4. T-cells in Alzheimer's disease.

5. Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Review 6. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.

Review 7. Amyloid-beta immunotherapy for Alzheimer's disease.

Review 8. Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice.

Review 9. CD4 T cells in immunity and immunotherapy of Alzheimer's disease.

Review 10. Immunotherapy for Alzheimer's disease.